Bulletin
Investor Alert

EyePoint Pharmaceuticals Inc.

NAS: EYPT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 18, 2022, 4:01 p.m.

/zigman2/quotes/210537129/composite

$

10.50

Change

0.00 0.00%

Volume

Volume 2,911

Quotes are delayed by 20 min

/zigman2/quotes/210537129/composite

Today's close

$ 10.60

$ 10.50

Change

-0.10 -0.94%

Day low

Day high

$10.20

$10.61

Open

52 week low

52 week high

$7.00

$21.50

Open

Insider Actions for EyePoint Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/04/2020 George O. Elston
Chief Financial Officer
10,000   Acquisition at $0.48 per share. 4,800
08/24/2020 George O. Elston
Chief Financial Officer
10,000   Acquisition at $0.61 per share. 6,100
06/30/2020 Nancy Sue Lurker
President & CEO; Director
124,667   Derivative/Non-derivative trans. at $0 per share. 0
06/30/2020 Dario A. Paggiarino
Chief Medical Officer
41,050   Derivative/Non-derivative trans. at $0 per share. 0
06/30/2020 Scott Jones
SVP & Chief Commercial Officer
41,050   Derivative/Non-derivative trans. at $0 per share. 0
06/30/2020 Dario A. Paggiarino
Chief Medical Officer
12,049   Derivative/Non-derivative trans. at $0.76 per share. 9,157
06/30/2020 Scott Jones
SVP & Chief Commercial Officer
14,060   Derivative/Non-derivative trans. at $0.76 per share. 10,685
06/27/2020 Nancy Sue Lurker
President & CEO; Director
40,000   Derivative/Non-derivative trans. at $0 per share. 0
06/27/2020 Dario A. Paggiarino
Chief Medical Officer
10,000   Derivative/Non-derivative trans. at $0 per share. 0
06/27/2020 Dario A. Paggiarino
Chief Medical Officer
2,936   Derivative/Non-derivative trans. at $0.79 per share. 2,319
06/14/2020 Nancy Sue Lurker
President & CEO; Director
45,000   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2020 Dario A. Paggiarino
Chief Medical Officer
14,200   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2020 Dario A. Paggiarino
Chief Medical Officer
4,168   Derivative/Non-derivative trans. at $0.83 per share. 3,459
03/12/2020 George O. Elston
Chief Financial Officer
10,000   Acquisition at $0.96 per share. 9,600
03/10/2020 Nancy Sue Lurker
President & CEO; Director
98,000   Acquisition at $1.06 per share. 103,880
02/21/2020 Nancy Sue Lurker
President & CEO; Director
137,174   Derivative/Non-derivative trans. at $0 per share. 0
11/15/2019 George O. Elston
Chief Financial Officer
10,000   Acquisition at $1.43 per share. 14,300
10/12/2019 Nancy Sue Lurker
President & CEO; Director
10,745   Derivative/Non-derivative trans. at $2.1 per share. 22,564
10/12/2019 Dario A. Paggiarino
Chief Medical Officer
2,450   Derivative/Non-derivative trans. at $2.1 per share. 5,145

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
0 Purchases
0 Sales
0
0

Officers and Executives

Dr. Jay S. Duker
Chief Operating Officer
Mr. George O. Elston
CFO & Head-Corporate Development
Dr. Said Saim
Chief Technology Officer
Dr. Dario A. Paggiarino
Chief Medical Officer & Senior Vice President
Ms. Jennifer Leonard
Chief People Officer & Senior Vice President-IT
Mr. Scott Jones
Chief Commercial Officer & Senior Vice President
Mr. Michael C. Pine
Chief Corporate Development & Strategy Officer
Mr. Ye Liu
Director
Dr. Anthony P. Adamis
Director
Ms. Karen L. Zaderej
Director
Mr. Ron I. Honig
Secretary, Chief Legal Officer & Senior VP
Ms. Isabelle Lefebvre
Chief Regulatory Officer
Dr. Göran Albert Torstensson Ando
Non-Executive Chairman
Ms. Wendy F. DiCicco
Independent Director
Dr. John Barry Landis
Independent Director
Dr. David R. Guyer
Independent Director
Link to MarketWatch's Slice.